Brainstorm Cell Therapeutics

$9.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.64 (-6.31%) Today
+$0.19 (+2.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BCLI and other stocks, options, and ETFs commission-free!

About BCLI

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. Read More The company was founded on September 22, 2000 and is headquartered in New York, NJ. The listed name for BCLI is Brainstorm Cell Therapeutics Inc. Common Stock.

Employees
32
Headquarters
New York, New York
Founded
2000
Market Cap
300.21M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.17M
High Today
$10.80
Low Today
$9.31
Open Price
$10.34
Volume
1.60M
52 Week High
$17.95
52 Week Low
$3.58

Collections

BCLI Earnings

-$0.34
-$0.25
-$0.16
-$0.07
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
-$0.26 per share
Actual
-$0.14 per share

You May Also Like